ALFApump System Post Marketing Surveillance Registry

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

NCT03200106 ·Status: COMPLETED

Alfapump-albumin Replacement Therapy

NCT02448160 ·Status: TERMINATED ·Phase: NA

Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients

NCT03506893 ·Status: RECRUITING ·Phase: NA

Malignant Ascites Alfapump® Study

NCT04076566 ·Status: WITHDRAWN

Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)

NCT03973866 ·Status: UNKNOWN ·Phase: NA

Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites

NCT02163512 ·Status: COMPLETED

Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics

NCT02818673 ·Status: UNKNOWN ·Phase: PHASE3

Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis

NCT01288794 ·Status: COMPLETED ·Phase: PHASE4

Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis

NCT03550690 ·Status: UNKNOWN

Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites

NCT03451292 ·Status: COMPLETED ·Phase: PHASE3

A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests

NCT07087041 ·Status: NOT_YET_RECRUITING

Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .

NCT03084185 ·Status: UNKNOWN

The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study

NCT01091233 ·Status: WITHDRAWN

Outcomes Using MARS for Patients With ALF

NCT05594953 ·Status: UNKNOWN

Evaluation of 'Melody' Paracentesis Device for Ascites Therapy

NCT03191851 ·Status: COMPLETED ·Phase: NA

Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure

NCT01471028 ·Status: COMPLETED ·Phase: PHASE3

Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis

NCT07072572 ·Status: COMPLETED ·Phase: PHASE3

Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

NCT05056220 ·Status: RECRUITING ·Phase: PHASE3

Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients

NCT04216784 ·Status: TERMINATED ·Phase: PHASE4

Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"

NCT01201720 ·Status: COMPLETED ·Phase: NA

Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites

NCT03069131 ·Status: COMPLETED ·Phase: PHASE3

Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery

NCT01435421 ·Status: UNKNOWN

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

NCT06855056 ·Status: RECRUITING

Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units

NCT01079104 ·Status: TERMINATED ·Phase: NA

Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy

NCT05772585 ·Status: WITHDRAWN